Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BEVACIZUMAB vs BEXAROTENE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BEVACIZUMAB vs BEXAROTENE: Safety Overview

Metric BEVACIZUMAB BEXAROTENE
Total FAERS Reports 78,112 759
Deaths Reported 17,498 134
Death Rate 22.4% 17.7%
Hospitalizations 23,114 177
Average Patient Age 61.1 yrs 66.5 yrs
% Female Patients 55.0% 42.3%
FDA Approval Date N/A Apr 27, 2022
Manufacturer Biocon Biologics Inc. Upsher-Smith Laboratories, Inc.
Route INTRAVASCULAR ORAL
Marketing Status Prescription Prescription